SHED vs Hims for GLP-1 Weight Loss (2026): Honest Cost, Meds & Best Fit

By Weight Loss Provider Guide Editorial Team · Published April 21, 2026 · Last verified April 21, 2026 · Full disclosure ↓

Independent comparison resource. We earn a commission on both SHED and Hims referrals. Where Hims wins, we say so plainly — see the cost sections and cancellation table below.

Pick SHED if you want real format flexibility — compounded injections, sublingual drops, lozenges, or oral tablets — with all-in pricing and a 9-month weight-loss money-back guarantee. Pick Hims if you want FDA-approved brand-name medications on a mainstream consumer platform: Wegovy pill from $149/mo, Wegovy pen from $199/mo, Ozempic from $199/mo, plus Mounjaro and Zepbound at $1,899/mo cash-pay, all on top of a $149/mo Hims Weight Loss Membership.

If you came in assuming Hims was the cheap compounded option — that changed in February and March 2026. Hims reached a settlement and partnership with Novo Nordisk, pivoted to FDA-approved medications as the main offer, and now keeps compounded semaglutide only on a limited, clinically-necessary basis. Most comparison pages haven’t caught up yet.

Quick verdict: SHED vs Hims at a glance

Editorial infographic showing decision factors for both providers. Compounded medications are not FDA-approved as finished products. Last verified April 21, 2026.

What changed at Hims in 2026 — and why older comparisons are wrong

Hims pricing (verified April 21, 2026)

Hims separates medication from membership — cleaner math, but you always see two charges, not one.

For Mounjaro or Zepbound through insurance or lower cash-pay pricing, see Ro’s insurance concierge →

SHED pricing (verified April 21, 2026)

SHED’s compounded formats vs Hims’ FDA-approved menu. Both providers showed pricing inconsistencies across their own pages in April 2026 — verify at checkout.

The SHED pricing conflict — our original research

Conflict #1 — Compounded tirzepatide

• The dedicated compounded tirzepatide injections page says $299/mo
• The weight-loss category page says $399/mo for compounded tirzepatide

Conflict #2 — Branded Wegovy / Foundayo membership

• Parts of SHED’s Wegovy page reference a $99/mo subscription with medication at $149 (pill) / $199 (pen)
• Other parts of the same page show a $125/mo membership with medication at $349–$499
• Foundayo on SHED appears at $149/mo alongside either the $99 or $125 membership depending on the section

A realistic 12-month cost sketch

Format flexibility — SHED’s biggest edge, clarified

Needle-free options breakdown

SHED offers the broadest compounded non-injection menu: sublingual drops ($229/mo), lozenges ($199/mo), and oral tablets ($299/mo). Hims offers the FDA-approved Wegovy pill ($149/mo + membership) and nothing else on the GLP-1 oral side. Hims’ non-GLP-1 oral kits starting at $69/month are not GLP-1 therapy.

If needle-free plus FDA approval are both requirements, the FDA-approved oral options in April 2026 are:

• Wegovy pill — available on Hims directly, or SHED’s brand pathway
• Foundayo — not currently on Hims’ main platform; Ro carries it directly →

Who should pick SHED, who should pick Hims, who should skip both

Pick SHED if…

• You want to start or stay on compounded semaglutide or tirzepatide at the lowest all-in price
• Your top priority is avoiding injections — SHED has the widest non-injection compounded menu
• You want format flexibility: drops, lozenges, tablets, or injections from one platform
• Price-sensitive shoppers who want compounded with no separate membership
• First-time GLP-1 users who value the 9-month money-back guarantee and can meet participation requirements
• You want Foundayo via brand pathway, or are interested in microdose GLP-1 protocols
• Direct HSA/FSA card checkout matters to you

Pick Hims if…

• You want the FDA-approved Wegovy pill at $149/mo on a mainstream consumer platform
• You want a broader FDA-approved menu (Wegovy, Ozempic, Mounjaro, Zepbound) in one place
• You value 24/7 care-team messaging and operational consistency
• The $149/mo membership (after the $39 first month) is acceptable to you for that convenience
• You want flexible membership cancellation with no minimum term

Skip both if…

• You need FDA-approved medication manufactured by the brand holder only, and want insurance billed → Ro is the cleaner pick
• You want month-to-month flexibility without a 2-month minimum → Hims membership has no minimum
• You want insurance billed and prior-auth handled → Ro's insurance concierge
• You need Foundayo directly at the lowest path → LillyDirect or Ro carry it; SHED has it via brand pathway; Hims does not currently offer it

Decision guide: SHED vs Hims vs Ro depending on your priorities. Last verified April 21, 2026.

SHED deep dive — what you’re actually getting

SHED (tryshed.com) is a telehealth weight-loss platform with 150,000+ members, available in all 50 states and not in Puerto Rico. You get compounded semaglutide or tirzepatide in injection, drop, lozenge, or tablet form, plus a separate brand-name pathway for Wegovy, Zepbound, and Foundayo. SHED’s real differentiator is format variety paired with a 9-month weight-loss money-back guarantee for eligible first-time GLP-1 users.

What’s included in a standard SHED subscription

• Compounded medication from licensed 503A or 503B pharmacies
• Syringes, alcohol wipes, and a sharps container for injectables
• Free text-based health coaching included with Shed Membership
• Access to SHED's care team via chat and patient portal
• Shipping in 5–10 business days typically
• Monthly refills with provider check-in

What costs extra on SHED

• Premium coaching program: $49.99/month — one-on-one coaching plus a longer-term plan
• Labs: if required by your provider, billed separately (rare)
• Brand-name pathway: $99 or $125/month subscription (conflicted across SHED’s own pages) plus medication at pharmacy pricing

The 9-month guarantee — full fine print

SHED dealbreakers (verified)

• Pricing inconsistencies across SHED's own pages — screenshot checkout before committing
• 2-month minimum commitment before you can cancel
• 72-hour cancellation notice required before next billing date
• Refunds not issued once medication has shipped
• No direct insurance billing for GLP-1 medications

Hims deep dive — the broadest FDA-approved menu on a mainstream consumer platform

Hims is a publicly traded consumer telehealth platform (NYSE: HIMS). Following the March 26, 2026 Novo Nordisk partnership, Hims offers Wegovy pill from $149/mo, Wegovy pen from $199/mo, Ozempic from $199/mo, Mounjaro and Zepbound at $1,899/mo cash-pay, and generic liraglutide from $299/mo, all on top of a $149/mo Hims Weight Loss Membership ($39 for the first month). Hims still offers compounded semaglutide on a limited basis when a provider determines it is clinically necessary.

What’s in the Hims Weight Loss Membership

• Provider consultation and ongoing prescription evaluation
• 24/7 care team messaging
• Nutrition guidance and educational content
• Community and peer support access
• Async intake in most states; video visits where required

What costs extra on Hims

• The medication itself — the membership does not include medication
• Prepaid medication plans (3, 6, 10, or 12 months) for lower per-month cost — nonrefundable after medication ships
• Labs if required — rare, billed separately

Hims dealbreakers

• Membership and medication are two separate charges — easy to miss under headline pricing
• Membership steps up from $39 to $149/month starting month two
• No direct insurance billing or prior-authorization support — use Ro for that
• No Foundayo on the main platform as of April 21, 2026
• Specific GLP-1 medications not yet available in all 50 states
• No needle-free compounded options (drops, lozenges) — Wegovy pill is the only oral GLP-1

Cancellation: the friction nobody reads until it’s too late

State availability, HSA/FSA, and insurance

SHED is available in all 50 U.S. states and not in Puerto Rico. Hims’ platform is in all 50 states, but specific GLP-1 medications have state-by-state availability still rolling out under the Novo partnership. Neither SHED nor Hims bills insurance directly for GLP-1 medications. SHED accepts HSA and FSA cards directly at checkout; Hims recommends paying with a regular card and submitting for reimbursement.

If your decision hinges on getting Wegovy or Zepbound through insurance: Ro’s insurance concierge → is the right fit. Ro currently offers intro pricing of $39 for the first month, then as low as $74/month with annual prepay, plus prior-authorization support and a free GLP-1 Insurance Coverage Checker.

If you have an FSA with a “use it or lose it” December deadline, or an HSA balance you actively manage, the difference between direct card checkout and reimbursement workflow matters. See: How SHED’s HSA/FSA checkout works →

What real customers say (service signals, not medical claims)

Trustpilot snapshots captured April 21, 2026 showed SHED at 4.6/5 from 882 reviews and Hims at 3.0/5 from 8,125 reviews across all Hims product categories. These are service signals — not medical efficacy evidence — and individual experiences vary.

Individual results vary. Testimonials do not establish typical medical outcomes. Quotes are third-party service feedback.

How we actually verified this comparison

We verified every price and policy claim by visiting official product pages directly in April 2026. Where pages conflicted with each other, we documented both numbers. No affiliate considerations influenced what we reported.

Every figure in this comparison was pulled directly from official provider pages, screenshotted with timestamp, and noted for conflicts. Where prices differed between pages on the same site, we reported both numbers. Where a claim was sourced to a third party (FDA, Trustpilot, Novo Nordisk investor relations), we linked to the original. No affiliate consideration influenced what we said about either provider.

Frequently asked questions

Still not sure which fits you?

If you read all the way through and still feel pulled in two directions — that’s useful. It usually means your priorities are in tension: “I want needle-free, FDA-approved, cheap, and insurance-billed” is a four-way trade-off that no single provider solves perfectly.

What to do next

• Needle-free options or cheapest compounded path → Check eligibility on SHED
• FDA-approved Wegovy pill or pen → See current Hims pricing
• Insurance billed for Wegovy, Zepbound, or Foundayo → See Ro’s insurance concierge
• Still deciding → Take the 60-second matching quiz